These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

533 related articles for article (PubMed ID: 12727932)

  • 1. Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A.
    Holtwick R; van Eickels M; Skryabin BV; Baba HA; Bubikat A; Begrow F; Schneider MD; Garbers DL; Kuhn M
    J Clin Invest; 2003 May; 111(9):1399-407. PubMed ID: 12727932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelium is critically involved in the hypotensive and hypovolemic actions of atrial natriuretic peptide.
    Sabrane K; Kruse MN; Fabritz L; Zetsche B; Mitko D; Skryabin BV; Zwiener M; Baba HA; Yanagisawa M; Kuhn M
    J Clin Invest; 2005 Jun; 115(6):1666-74. PubMed ID: 15931395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypervolemic hypertension in mice with systemic inactivation of the (floxed) guanylyl cyclase-A gene by alphaMHC-Cre-mediated recombination.
    Skryabin BV; Holtwick R; Fabritz L; Kruse MN; Veltrup I; Stypmann J; Kirchhof P; Sabrane K; Bubikat A; Voss M; Kuhn M
    Genesis; 2004 Aug; 39(4):288-98. PubMed ID: 15287002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure.
    Kuhn M; Voss M; Mitko D; Stypmann J; Schmid C; Kawaguchi N; Grabellus F; Baba HA
    Cardiovasc Res; 2004 Nov; 64(2):308-14. PubMed ID: 15485690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced activity of the myocardial Na+/H+ exchanger NHE-1 contributes to cardiac remodeling in atrial natriuretic peptide receptor-deficient mice.
    Kilic A; Velic A; De Windt LJ; Fabritz L; Voss M; Mitko D; Zwiener M; Baba HA; van Eickels M; Schlatter E; Kuhn M
    Circulation; 2005 Oct; 112(15):2307-17. PubMed ID: 16216978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy.
    Kishimoto I; Rossi K; Garbers DL
    Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2703-6. PubMed ID: 11226303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered expression of atrial natriuretic peptide and contractile protein genes in hypertrophied ventricle of JVS mice with systemic carnitine deficiency.
    Yoshimine K; Horiuchi M; Suzuki S; Kobayashi K; Abdul JM; Masuda M; Tomomura M; Ogawa Y; Itoh H; Nakao K; Osame M; Saheki T
    J Mol Cell Cardiol; 1997 Feb; 29(2):571-8. PubMed ID: 9140816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of TRPC6 channel activity contributes to the antihypertrophic effects of natriuretic peptides-guanylyl cyclase-A signaling in the heart.
    Kinoshita H; Kuwahara K; Nishida M; Jian Z; Rong X; Kiyonaka S; Kuwabara Y; Kurose H; Inoue R; Mori Y; Li Y; Nakagawa Y; Usami S; Fujiwara M; Yamada Y; Minami T; Ueshima K; Nakao K
    Circ Res; 2010 Jun; 106(12):1849-60. PubMed ID: 20448219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guanylyl cyclase-A inhibits angiotensin II type 1A receptor-mediated cardiac remodeling, an endogenous protective mechanism in the heart.
    Li Y; Kishimoto I; Saito Y; Harada M; Kuwahara K; Izumi T; Takahashi N; Kawakami R; Tanimoto K; Nakagawa Y; Nakanishi M; Adachi Y; Garbers DL; Fukamizu A; Nakao K
    Circulation; 2002 Sep; 106(13):1722-8. PubMed ID: 12270869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased susceptibility to heart failure in response to volume overload in mice lacking natriuretic peptide receptor-A gene.
    Nishikimi T; Hagaman JR; Takahashi N; Kim HS; Matsuoka H; Smithies O; Maeda N
    Cardiovasc Res; 2005 Apr; 66(1):94-103. PubMed ID: 15769452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcineurin-nuclear factor of activated T cells pathway-dependent cardiac remodeling in mice deficient in guanylyl cyclase A, a receptor for atrial and brain natriuretic peptides.
    Tokudome T; Horio T; Kishimoto I; Soeki T; Mori K; Kawano Y; Kohno M; Garbers DL; Nakao K; Kangawa K
    Circulation; 2005 Jun; 111(23):3095-104. PubMed ID: 15939815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen protects against the development of salt-induced cardiac hypertrophy in heterozygous proANP gene-disrupted mice.
    Sangaralingham SJ; Tse MY; Pang SC
    J Endocrinol; 2007 Jul; 194(1):143-52. PubMed ID: 17592028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of natriuretic peptides and their receptors in volume overload cardiac hypertrophy in the rat.
    Su X; Brower G; Janicki JS; Chen YF; Oparil S; Dell'Italia LJ
    J Mol Cell Cardiol; 1999 Oct; 31(10):1927-36. PubMed ID: 10525429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulator of G-protein signaling subtype 4 mediates antihypertrophic effect of locally secreted natriuretic peptides in the heart.
    Tokudome T; Kishimoto I; Horio T; Arai Y; Schwenke DO; Hino J; Okano I; Kawano Y; Kohno M; Miyazato M; Nakao K; Kangawa K
    Circulation; 2008 May; 117(18):2329-39. PubMed ID: 18443239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ventricular expression of natriuretic peptides in Npr1(-/-) mice with cardiac hypertrophy and fibrosis.
    Ellmers LJ; Knowles JW; Kim HS; Smithies O; Maeda N; Cameron VA
    Am J Physiol Heart Circ Physiol; 2002 Aug; 283(2):H707-14. PubMed ID: 12124219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of natriuretic peptide receptor guanylyl cyclase-A in myocardial infarction evaluated using genetically engineered mice.
    Nakanishi M; Saito Y; Kishimoto I; Harada M; Kuwahara K; Takahashi N; Kawakami R; Nakagawa Y; Tanimoto K; Yasuno S; Usami S; Li Y; Adachi Y; Fukamizu A; Garbers DL; Nakao K
    Hypertension; 2005 Aug; 46(2):441-7. PubMed ID: 15998711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smooth muscle-selective deletion of guanylyl cyclase-A prevents the acute but not chronic effects of ANP on blood pressure.
    Holtwick R; Gotthardt M; Skryabin B; Steinmetz M; Potthast R; Zetsche B; Hammer RE; Herz J; Kuhn M
    Proc Natl Acad Sci U S A; 2002 May; 99(10):7142-7. PubMed ID: 11997476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local atrial natriuretic peptide signaling prevents hypertensive cardiac hypertrophy in endothelial nitric-oxide synthase-deficient mice.
    Bubikat A; De Windt LJ; Zetsche B; Fabritz L; Sickler H; Eckardt D; Gödecke A; Baba HA; Kuhn M
    J Biol Chem; 2005 Jun; 280(22):21594-9. PubMed ID: 15793309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel insights into the mechanisms mediating the local antihypertrophic effects of cardiac atrial natriuretic peptide: role of cGMP-dependent protein kinase and RGS2.
    Klaiber M; Kruse M; Völker K; Schröter J; Feil R; Freichel M; Gerling A; Feil S; Dietrich A; Londoño JE; Baba HA; Abramowitz J; Birnbaumer L; Penninger JM; Pongs O; Kuhn M
    Basic Res Cardiol; 2010 Sep; 105(5):583-95. PubMed ID: 20352235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary salt supplementation selectively downregulates NPR-C receptor expression in kidney independently of ANP.
    Sun JZ; Chen SJ; Majid-Hasan E; Oparil S; Chen YF
    Am J Physiol Renal Physiol; 2002 Feb; 282(2):F220-7. PubMed ID: 11788435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.